1329171-58-5Relevant articles and documents
Synthesis and P1′ SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors
Ladziata, Vladimir (Uladzimir),Glunz, Peter W.,Zou, Yan,Zhang, Xiaojun,Jiang, Wen,Jacutin-Porte, Swanee,Cheney, Daniel L.,Wei, Anzhi,Luettgen, Joseph M.,Harper, Timothy M.,Wong, Pancras C.,Seiffert, Dietmar,Wexler, Ruth R.,Priestley, E. Scott
, p. 5051 - 5057 (2016)
Selective tissue factor-factor VIIa complex (TF-FVIIa) inhibitors are viewed as promising compounds for treating thrombotic disease. In this contribution, we describe multifaceted exploratory SAR studies of S1′-binding moieties within a macrocyclic chemotype aimed at replacing cyclopropyl sulfone P1′ group. Over the course of the optimization efforts, the 1-(1H-tetrazol-5-yl)cyclopropane P1′ substituent emerged as an improved alternative, offering increased metabolic stability and lower clearance, while maintaining excellent potency and selectivity.